Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Health Catalyst, Inc. (HCAT : NSDQ)

• Company Description    Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. Number of Employees: 1,200

• Price / Volume Information    Yesterday's Closing Price: $1.29 Daily Weekly Monthly 20 Day Moving Average: 608,335 shares Shares Outstanding: 73.89 (millions) Market Capitalization: $95.32 (millions) Beta: 1.63 52 Week High: $4.29 52 Week Low: $0.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.01% -7.75% 12 Week -26.29% -31.85% Year To Date -46.03% -50.38%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10897 SOUTH RIVER FRONT PARKWAY #300 - SOUTH JORDAN,UT 84095 USA ph: 801-708-6800 fax: - ir@healthcatalyst.com http://www.healthcatalyst.com

• General Corporate Information    Officers Benjamin Albert - Chief Executive Officer and Director Jason Alger - Chief Financial Officer John A. Kane - Director Mathew Arens - Director Jill Hoggard Green - Director Peer Information Health Catalyst, Inc. (HLIS) Health Catalyst, Inc. (AZTA) Health Catalyst, Inc. (APYI) Health Catalyst, Inc. (RNVA) Health Catalyst, Inc. (HMSY) Health Catalyst, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 42225T107 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 73.89 Most Recent Split Date: (:1) Beta: 1.63 Market Capitalization: $95.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.28 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.69 Price/Cash Flow: 0.61 Price / Sales: 0.32 EPS Growth vs. Year Ago Period: 70.00% vs. Previous Quarter: -250.00% Sales Growth vs. Year Ago Period: -10.90% vs. Previous Quarter: -5.25% ROE 03/31/26 - -3.52 12/31/25 - -4.30 09/30/25 - -6.67 ROA 03/31/26 - -1.77 12/31/25 - -2.16 09/30/25 - -3.21 Current Ratio 03/31/26 - 1.69 12/31/25 - 1.89 09/30/25 - 1.88 Quick Ratio 03/31/26 - 1.69 12/31/25 - 1.89 09/30/25 - 1.88 Operating Margin 03/31/26 - -3.09 12/31/25 - -4.50 09/30/25 - -7.50 Net Margin 03/31/26 - -87.69 12/31/25 - -57.20 09/30/25 - -34.05 Pre-Tax Margin 03/31/26 - -87.39 12/31/25 - -56.97 09/30/25 - -33.75 Book Value 03/31/26 - 1.87 12/31/25 - 3.47 09/30/25 - 4.72 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 1.10 12/31/25 - 0.62 09/30/25 - 0.46 Debt-to-Capital 03/31/26 - 52.35 12/31/25 - 38.15 09/30/25 - 31.34

Powered by Zacks Investment Research ©